![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0043.png)
43
individuals at high clinical risk. Arch Gen
Psychiatry 2012;69:220-9.
41. Correll CU, Hauser M, Auther AM, Cornblatt
BA. Research in people with psychosis risk
syndrome: a review of the current evidence and
future directions. J Child Psychol Psychiatry
2010;51:390-431.
42. Yung AR, Nelson B, Stanford C, Simmons MB,
Cosgrave EM, Killackey E, et al. Validation of
"prodromal" criteria to detect individuals at ultra
high risk of psychosis: 2 year follow-up. Schizophr
Res 2008;105:10-7.
43. Yung AR, Nelson B, Thompson AD, Wood SJ.
Should a "Risk Syndrome for Psychosis" be
included in the DSMV? Schizophr Res 2010;120:7-
15.
44. Barnett JH, Werners U, Secher SM, Hill KE,
Brazil R, Masson K, et al. Substance use in a
population-based clinic sample of people with first-
episode psychosis. Br J Psychiatry 2007;190:515-20.
45. Arseneault L, Cannon M, Poulton R, Murray R,
Caspi A, Moffitt TE. Cannabis use in adolescence
and risk for adult psychosis: longitudinal
prospective study. BMJ 2002;325:1212-3.
46. McGrath J, Welham J, Scott J, Varghese D,
Degenhardt L, Hayatbakhsh MR, et al. Association
between cannabis use and psychosis-related